LB Pharmaceuticals Stock Price, News & Analysis
LBRX
NASDAQ
Company Description
Welcome to the overview page for LB Pharmaceuticals (LBRX), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$15.96
-1.05%
0.17
Last updated: November 2, 2025 at 15:59
-
Performance 1 year
$365.4M
20.1M
Latest News
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
JAN
01
January 1, 2026 - April 30, 2026
Clinical
Phase 3 acute schizophrenia trial
Initiation of Phase 3 trial for acute schizophrenia in early 2026
JAN
01
January 1, 2026 - April 30, 2026
Clinical
Phase 2 bipolar depression trial
Initiation of Phase 2 trial for bipolar depression in early 2026
JAN
01
January 1, 2026 - December 31, 2026
Clinical
Phase 3 trial start
Planned Phase 3 schizophrenia trial initiation
JAN
01
January 1, 2026 - December 31, 2026
Clinical
Phase 2 trial start
Planned Phase 2 bipolar depression trial initiation
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of LB Pharmaceuticals (LBRX)?
The current stock price of LB Pharmaceuticals (LBRX) is $16.13 as of October 31, 2025.
What is the market cap of LB Pharmaceuticals (LBRX)?
The market cap of LB Pharmaceuticals (LBRX) is approximately 365.4M. Learn more about what market capitalization means .